当前位置: 首页 SCI期刊 SCIE期刊 JCRQ4 期刊介绍(非官网)
Case Reports In Oncological Medicine

Case Reports In Oncological MedicineSCIE

国际简称:CASE REP ONCOL MED  参考译名:肿瘤医学病例报告

  • JCR分区

    Q4

基本信息:
ISSN:2090-6706
E-ISSN:2090-6714
是否OA:开放
是否预警:否
出版信息:
出版地区:United Kingdom
出版商:Hindawi Limited
出版语言:English
研究方向:ONCOLOGY
评价信息:
影响因子:0.6
发文数据:
Gold OA文章占比:97.96%
研究类文章占比:80.00%
年发文量:10
英文简介 期刊介绍 JCR分区 常见问题

英文简介Case Reports In Oncological Medicine期刊介绍

Case Reports in Oncology Medicine is a peer-reviewed open access journal focused on the field of oncology. This magazine publishes case reports related to various cancers, aiming to provide a platform for clinical doctors, researchers, and healthcare professionals to share unique cases, rare disease manifestations, treatment challenges, and innovative therapies. These case reports help to enhance understanding of cancer biology, diagnosis, treatment, and management, while also guiding future clinical practice and research directions.

The journal emphasizes the educational significance and scientific contribution of cases, encourages submission of detailed case descriptions, comprehensive literature reviews, and in-depth discussions. In this way, the magazine not only promotes the dissemination of individual case knowledge, but also helps to build a broader oncology community, thereby improving the quality of patient care worldwide. The types of contributions accepted by the magazine include single case reports and case series, and research topics cover a wide range of fields such as breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology, and urogenital cancer. These studies are of great significance for promoting clinical progress and personalized medicine in oncology.

期刊简介Case Reports In Oncological Medicine期刊介绍

《Case Reports In Oncological Medicine》该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

  • 预计审稿时间: 16 Weeks
  • SCIE
  • 非预警

JCR分区Case Reports In Oncological Medicine JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q4 299 / 322

7.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q4 298 / 322

7.61%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

投稿常见问题